share_log

Truist Securities Maintains Hold on Cross Country Healthcare, Raises Price Target to $18.61

Truist Securities Maintains Hold on Cross Country Healthcare, Raises Price Target to $18.61

Truist证券维持对cross country healthcare的持有评级,将目标价格提高到$18.61
Benzinga ·  2024/12/05 11:46  · 评级/大行评级

Truist Securities analyst Tobey Sommer maintains Cross Country Healthcare (NASDAQ:CCRN) with a Hold and raises the price target from $15 to $18.61.

Truist Securities 的分析师托比·索默维持对 cross country healthcare (纳斯达克:CCRN) 的持有评级,并将目标价从15美元上调至18.61美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发